Medicare Enrolled

Dr. Tien I Su, M.D.

Internal Medicine · Whittier, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Research-focused
12456 WASHINGTON BLVD, Whittier, CA 90602
5627586600
In practice since 2007 (18 years)
NPI: 1750581930 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Su from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Su? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Su

Dr. Tien I Su is an internal medicine specialist in Whittier, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Su performed 24,161 Medicare services across 503 unique beneficiaries.

Between the years covered by Open Payments, Dr. Su received a total of $13,579 from 27 pharmaceutical and/or device companies across 294 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. The majority of payments are classified as research and scientific activities (grants and research funding). Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Su is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ Top 1% volume in CA $13,579 industry payments

Medicare Practice Summary

Medicare Utilization ↗
24,161
Medicare services
Top 1% in CA for internal medicine
503
Unique beneficiaries
$13
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,342 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Romosozumab injection (Evenity) for osteoporosis 18,703 $8 $20
Denosumab injection (Prolia/Xgeva) 4,335 $18 $35
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
482 $98 $240
Non-hormonal chemotherapy injection
This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue.
308 $66 $165
Bone density scan (DEXA) of hip, pelvis, and spine
This test measures bone density in the hip, pelvis, and spine to assess bone strength. It also includes an assessment for spine fractures.
78 $59 $200
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
78 $119 $300
Zoledronic acid injection, 1 mg
An injection of zoledronic acid administered at a dose of 1 mg.
72 $6 $45
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
30 $62 $147
Injection, methylprednisolone acetate, 40 mg 26 $6 $15
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
20 $58 $150
Chronic care management, first 20 min/month
This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions.
18 $54 $190
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
11 $130 $320
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.4% high complexity
97.2% medium
2.4% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$13,579
Total received (2018-2024)
Avg $1,940/year across 7 years
Top 8% in CA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
27
Companies
294
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Scientific / Research
Research funding and grants
$7,686 (56.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,893 (43.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$8,529
2023
$818
2022
$695
2021
$638
2020
$267
2019
$1,070
2018
$1,563

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$7,686
Amgen Inc.
$192
PFIZER INC.
$169
Janssen Biotech, Inc.
$145
GENZYME CORPORATION
$137
Novartis Pharmaceuticals Corporation
$65
GlaxoSmithKline, LLC.
$65
Boehringer Ingelheim Pharmaceuticals, Inc.
$36
AstraZeneca Pharmaceuticals LP
$34
Top 3 companies account for 94.3% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$7,884
PFIZER INC.
$829
Amgen Inc.
$695
Novartis Pharmaceuticals Corporation
$592
AbbVie Inc.
$415
Janssen Biotech, Inc.
$403
GENZYME CORPORATION
$399
GlaxoSmithKline, LLC.
$312
Horizon Therapeutics plc
$286
E.R. Squibb & Sons, L.L.C.
$240
AbbVie, Inc.
$233
Genentech USA, Inc.
$227
Boehringer Ingelheim Pharmaceuticals, Inc.
$206
Cumberland Pharmaceuticals, Inc.
$139
Radius Health, Inc.
$122
Celgene Corporation
$121
UCB, Inc.
$112
Lilly USA, LLC
$72
Horizon Pharma plc
$67
AstraZeneca Pharmaceuticals LP
$48
Mallinckrodt LLC
$47
Actelion Pharmaceuticals US, Inc.
$34
Aurinia Pharma U.S., Inc.
$32
Bayer HealthCare Pharmaceuticals Inc.
$20
Hikma Pharmaceuticals USA
$19
MEDAC PHARMA, INC.
$15
United Therapeutics Corporation
$12
Top 3 companies account for 69.3% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AVSOLA · Actemra · Adempas · BENLYSTA · COSENTYX · Cimzia · EVENITY · Enbrel · FORTEO · HUMIRA · Humira · ILARIS · INFLECTRA · KEVZARA · KRYSTEXXA · LUPKYNIS · LYRICA · Mitigare · OFEV · OPSUMIT · ORENCIA · Otezla · PENNSAID · REDITREX · REMICADE · RINVOQ · Rasuvo · Repatha · Rinvoq · Rituxan · STELARA · TALTZ · TAVNEOS · TREMFYA · TYVASO · Tymlos · UPTRAVI · XELJANZ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (57%) are classified as scientific/research, suggesting involvement in clinical studies, grants, or innovation-related work. Total industry engagement is in the top 8% for internal medicine in CA.

Looking for an internal medicine specialist in Whittier?
Compare internal medicine physicians in the Whittier area by procedure volume, costs, and industry payment transparency.
Browse internal medicine physicians nearby

Geographic Context

Internal medicine physicians within 10 mi
4,911
Per 100K population
49.9
County median income
$87,760
Nearest hospital
PIH HEALTH HOSPITAL-WHITTIER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Su is a mixed practice specialist, with above-average Medicare volume (top 1% in CA), with research-focused industry engagement in the top 8% of CA peers, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Su experienced with romosozumab injection (evenity) for osteoporosis?
Based on Medicare claims data, Dr. Su performed 18,703 romosozumab injection (evenity) for osteoporosis services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Su receive payments from pharmaceutical companies?
Yes. Dr. Su received a total of $13,579 from 27 companies across 294 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Su's costs compare to other internal medicine physicians in Whittier?
Dr. Su's average Medicare payment per service is $13. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Su) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →